1.Tita, ATN, Andrews, WW. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol. 2010; 37, 339–354.
2.Sperling, RS, Newton, E, Gibbs, RS. Intraamniotic infection in low-birth-weight infants. J Infect Dis. 1988; 157, 113–117.
3.Pugni, L, Pietrasanta, C, Acaia, B, et al. Chorioamnionitis and neonatal outcome in preterm infants: a clinical overview. J Matern Fetal Neonatal Med. 2016; 29, 1525–1529.
4.Galinsky, R, Polglase, GR, Hooper, SB, Black, MJ, Moss, TJM. The consequences of chorioamnionitis: preterm birth and effects on development. J Pregnancy. 2013; 2013, 412831.
5.Ruff, CA, Faulkner, SD, Rumajogee, P, et al. The extent of intrauterine growth restriction determines the severity of cerebral injury and neurobehavioural deficits in rodents. PLoS One. 2017; 12, e0184653.
6.Tolcos, M, Petratos, S, Hirst, JJ, et al. Blocked, delayed, or obstructed: What causes poor white matter development in intrauterine growth restricted infants? Prog Neurobiol. 2017; 154, 62–77.
7.Spencer, SJ, Meyer, U. Perinatal programming by inflammation. Brain Behav Immun. 2017; 63, 1–7.
8.Schendel, DE, Schuchat, A, Thorsen, P. Public health issues related to infection in pregnancy and cerebral palsy. Ment Retard Dev Disabil Res Rev. 2002; 8, 39–45.
9.Romero, R, Gomez, R, Ghezzi, F, et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol. 1998; 179, 186–193.
10.Zhang, Q, Lu, HY, Wang, JX, et al. Relationship between placental inflammation and fetal inflammatory response syndrome and brain injury in preterm infants. Zhongguo Dang Dai Er Ke Za Zhi. 2015; 17, 217–221.
11.Gotsch, F, Romero, R, Kusanovic, JP, et al. The fetal inflammatory response syndrome. Clin Obstet Gynecol. 2007; 50, 652–683.
12.Patras, KA, Nizet, V. Group B Streptococcal Maternal Colonization and Neonatal Disease: Molecular Mechanisms and Preventative Approaches. Front Pediatr. 2018; 6, 27.
13.Regan, JA, Klebanoff, MA, Nugent, RP, et al. Colonization with group B streptococci in pregnancy and adverse outcome. Am J Obstet Gynecol. 1996; 174, 1354–1360.
14.Teatero, S, Ferrieri, P, Martin, I, et al. Serotype distribution, population structure, and antimicrobial resistance of group b streptococcus strains recovered from colonized pregnant women. J Clin Microbiol. 2017; 55, 412–422.
15.Lu, B, Wu, J, Chen, X, et al. Microbiological and clinical characteristics of Group B Streptococcus isolates causing materno-neonatal infections: high prevalence of CC17/PI-1 and PI-2b sublineage in neonatal infections. J Med Microbiol. 2018; 67, 1551–1559.
16.O’Riordan, K, Lee, JC. Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev. 2004; 17, 218–234.
17.Lemire, P, Houde, M, Lecours, MP, Fittipaldi, N, Segura, M. Role of capsular polysaccharide in Group B Streptococccus interactions with dendritic cells. Microbes Infect. 2012; 14, 1064–1076.
18.Joubrel, C, Tazi, A, Six, A, et al. Group B streptococcus neonatal invasive infections, France 2007-2012. Clin Microbiol Infect. 2015; 21, 910–916.
19.Périchon, B, Szili, N, du Merle, L, et al. Regulation of PI-2b pilus expression in hypervirulent Streptococcus agalactiae ST-17 BM110. PLoS One. 2017; 12, e0169840.
20.Andrade, EB, Magalhães, A, Puga, A, et al. A mouse model reproducing the pathophysiology of neonatal group B streptococcal infection. Nat Commun. 2018; 9, 3138.
21.Allard, M-J, Bergeron, JD, Baharnoori, M, et al. A sexually dichotomous, autistic-like phenotype is induced by Group B Streptococcus maternofetal immune activation. Autism Res. 2017; 10, 233–245.
22.Bergeron, J, Gerges, N, Guiraut, C, et al. Activation of the IL-1β/CXCL1/MMP-10 axis in chorioamnionitis induced by inactivated Group B Streptococcus. Placenta. 2016; 47, 116–123.
23.Bergeron, JDL, Deslauriers, J, Grignon, S, et al. White matter injury and autistic-like behavior predominantly affecting male rat offspring exposed to group B streptococcal maternal inflammation. Dev Neurosci. 2013; 35, 504–515.
24.Lee, JC, Perez, NE, Hopkins, CA, Pier, GB. Purified capsular polysaccharide-induced immunity to Staphylococcus aureus infection. J Infect Dis. 1988; 157, 723–730.
25.Tobias, J, Svennerholm, AM, Carlin, NI, Lebens, M, Holmgren, J. Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice. Vaccine. 2011; 29, 8863–8869.
26.Simon, P, Dupuis, R, Costentin, J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res. 1994; 61, 59–64.
27.Deslauriers, J, Racine, W, Sarret, P, Grignon, S. Preventive effect of α-lipoic acid on prepulse inhibition deficits in a juvenile two-hit model of schizophrenia. Neuroscience. 2014; 272, 261–270.
28.Porambo, M, Phillips, AW, Marx, J, et al. Transplanted glial restricted precursor cells improve neurobehavioral and neuropathological outcomes in a mouse model of neonatal white matter injury despite limited cell survival. Glia. 2015; 63, 452–465.
29.Paxinos, G, Watson, C, Calabrese, E, Badea, A. MRI/DTI Atlas of the Rat Brain, 2015. Academic Press: Cambridge, MA.
30.Brochu, M-E, Girard, S, Lavoie, K, Sébire, G. Developmental regulation of the neuroinflammatory responses to LPS and/or hypoxia-ischemia between preterm and term neonates: an experimental study. J Neuroinflammation. 2011; 8, 55.
31.Wixey, JA, Chand, KK, Colditz, PB, Bjorkman, ST. Review: Neuroinflammation in intrauterine growth restriction. Placenta. 2017; 54, 117–154.
32.Blair, EM, Nelson, KB. Fetal growth restriction and risk of cerebral palsy in singletons born after at least 35 weeks’ gestation. Am J Obstet Gynecol. 2015; 212, 520.e1–7.
33.Dupin, R, Laurent, JP, Stauder, JE, Saliba, E. Auditory attention processing in 5-year-old children born preterm: evidence from event-related potentials. Dev Med Child Neurol. 2000; 42, 476–480.
34.Ferrari, A, Sghedoni, A, Alboresi, S, Pedroni, E, Lombardi, F. New definitions of 6 clinical signs of perceptual disorder in children with cerebral palsy: an observational study through reliability measures. Eur J Phys Rehabil Med. 2014; 50, 709–716.
35.Squarzoni, P, Thion, MS, Garel, S. Neuronal and microglial regulators of cortical wiring: usual and novel guideposts. Front Neurosci. 2015; 9, 238.
36.Paolicelli, RC, Ferretti, MT. Function and Dysfunction of Microglia during Brain Development: Consequences for Synapses and Neural Circuits. Front Synaptic Neurosci. 2017; 9, 9.
37.Tolsa, CB, Zimine, S, Warfield, SK, et al. Early alteration of structural and functional brain development in premature infants born with intrauterine growth restriction. Pediatr Res. 2004; 56, 132–138.
38.Hagemeyer, N, Hanft, KM, Akriditou, MA, et al. Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood. Acta Neuropathol. 2017; 134, 441–458.
39.Winram, SB, Jonas, M, Chi, E, Rubens, CE. Characterization of group B streptococcal invasion of human chorion and amnion epithelial cells in vitro. Infect Immun. 1998; 66, 4932–4941.
40.Lemire, P, Roy, D, Fittipaldi, N, et al. Implication of TLR- but not of NOD2-signaling pathways in dendritic cell activation by group B Streptococcus serotypes III and V. PLoS One. 2014; 9, e113940.
41.Russell, NJ, Seale, AC, O’Driscoll, M, et al. Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017; 65, S100–S111.
42.Gilman-Sachs, A, Dambaeva, S, Salazar Garcia, MD, et al. Inflammation induced preterm labor and birth. J Reprod Immunol. 2018; 129, 53–58.
43.Kemp, MW. Preterm birth, intrauterine infection, and fetal inflammation. Front Immunol. 2014; 5, 574.
44.Wang, X, Rousset, CI, Hagberg, H, Mallard, C. Lipopolysaccharide-induced inflammation and perinatal brain injury. Semin Fetal Neonatal Med. 2006; 11, 343–353.
45.Boveri, M, Kinsner, A, Berezowski, V, et al. Highly purified lipoteichoic acid from gram-positive bacteria induces in vitro blood-brain barrier disruption through glia activation: role of pro-inflammatory cytokines and nitric oxide. Neuroscience. 2006; 137, 1193–1209.